Zahra Castel-Ajgal

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Manuel Rodrigues, Giulia Vanoni, Pierre Loap et al. · Nature Communications · 2023 · 52 citations · Full text

Medicine, Immunology, Oncology +17

Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab

Zahra Castel-Ajgal, Claire Goulvestre, Sonia Zaibet et al. · Clinical Genitourinary Cancer · 2022 · 33 citations

Life Sciences, Immunology, Oncology +14

REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study

Charles Vauchier, Édouard Auclin, Philippe Barthélémy et al. · Journal of Oncology · 2022 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers

Édith Borcoman, Ana I. Lalanne, Jean‐Pierre Delord et al. · European Journal of Cancer · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacology +13

The genomic and transcriptomic landscape of metastastic urothelial cancer

Yohann Loriot, Maud Kamal, Laurène Syx et al. · Nature Communications · 2024 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +17